The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $2,326.86 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,566,748,095 units of the drug lisdexamfetamine 50 mg capsules. The contract has an ultimate completion date of December 18, 2024. Dakota Drug, Inc. is a key supplier of pharmaceuticals, medical supplies, and healthcare equipment to the DLA, with a focus on supporting U.S. Armed Forces medical operations. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which enables it to efficiently deliver a wide range of critical medical items to various defense healthcare facilities. This contract award is part of the DLA Troop Support Medical's ECAT Generation V Program and is not set aside.
Generated 3/18/25, 9:50 AM